Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT01024712 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: gefitinib
DRUG: paclitaxel
PROCEDURE: quality-of-life assessment

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences